Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrogen attached directly or indirectly to the purine ring...
Reexamination Certificate
2006-03-17
2010-02-02
Wilson, James O (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Nitrogen attached directly or indirectly to the purine ring...
C544S367000
Reexamination Certificate
active
07655798
ABSTRACT:
Crystalline aripiprazole Type II can be formed without solid state heat treatment. Instead a liquid is used such as in crystallizing from a solvent, especially 2-propanol, dimethyl sulfoxide, or a combination thereof with ethyl acetate, or in a solvent mediated solid-solid transformation, typically in ethyl acetate.
REFERENCES:
patent: 4734416 (1988-03-01), Banno et al.
patent: 5006528 (1991-04-01), Oshiro et al.
patent: 2004/0058935 (2004-03-01), Bando et al.
patent: 2006/0142299 (2006-06-01), Ettema et al.
patent: 2006/0142579 (2006-06-01), Ettema et al.
patent: 367141 (1996-01-01), None
patent: WO 03/026659 (2003-04-01), None
patent: WO 2005/058835 (2005-06-01), None
Fabrizia Grepioni, New Journal Of Chemistry; Polymorphism and crystal Forms; 2008, 32, 1657-1658.
“Study on Crystal Transformation of Aripiprazole” The Fourth Japan-Korea Symposium on Separation Technology (1996), pp. 937-940.
Ettema Gerrit J. B.
Kalmoua Faysal
Westheim Raymond J. H.
Buscher Mark R.
Sackey Ebenezer
Synthon BV
Wilson James O
LandOfFree
Process of making crystalline Type II aripiprazole does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process of making crystalline Type II aripiprazole, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process of making crystalline Type II aripiprazole will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4219774